Dataset Information


Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping.

ABSTRACT: The recent identification of compounds that interact with the spliceosome (sudemycins, spliceostatin A, and meayamycin) indicates that these molecules modulate aberrant splicing via SF3B1 inhibition. Through whole transcriptome sequencing, we have demonstrated that treatment of Rh18 cells with sudemycin leads to exon skipping as the predominant aberrant splicing event. This was also observed following reanalysis of published RNA-seq data sets derived from HeLa cells after spliceostatin A exposure. These results are in contrast to previous reports that indicate that intron retention was the major consequence of SF3B1 inhibition. Analysis of the exon junctions up-regulated by these small molecules indicated that these sequences were absent in annotated human genes, suggesting that aberrant splicing events yielded novel RNA transcripts. Interestingly, the length of preferred downstream exons was significantly longer than the skipped exons, although there was no difference between the lengths of introns flanking skipped exons. The reading frame of the aberrantly skipped exons maintained a ratio of 2:1:1, close to that of the cassette exons (3:1:1) present in naturally occurring isoforms, suggesting negative selection by the nonsense-mediated decay (NMD) machinery for out-of-frame transcripts. Accordingly, genes involved in NMD and RNAs encoding proteins involved in the splicing process were enriched in both data sets. Our findings, therefore, further elucidate the mechanisms by which SF3B1 inhibition modulates pre-mRNA splicing.


PROVIDER: S-EPMC6049506 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4005683 | BioStudies
2016-01-01 | S-EPMC5029572 | BioStudies
1000-01-01 | S-EPMC4138523 | BioStudies
2017-01-01 | S-EPMC5458519 | BioStudies
2013-01-01 | S-EPMC3657302 | BioStudies
2015-01-01 | S-EPMC4673195 | BioStudies
2018-01-01 | S-EPMC6097662 | BioStudies
2019-01-01 | S-EPMC6430687 | BioStudies
2020-01-01 | S-EPMC7050488 | BioStudies
2011-01-01 | S-EPMC3019111 | BioStudies